Right now, today, Republican Representative Tom McClintock and Democratic Representative Jared Polis are circulating a letter in support of their amendment to defund the Department of Justice’s ability to enforce federal prohibition in the states that have reformed their marijuana laws, both for medical and responsible adult-use.
Today, sixty-four members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.
On Wednesday, October 11th, Congressional Cannabis Caucus Co-Chair Earl Blumenauer (D-OR) testified before the House Energy & Commerce Subcommittee on Health on how to deal with the opioid crisis in America.
The Cannabis Fund, a PAC created by Representative Earl Blumenauer to support cannabis-friendly candidates, will be hosting its first annual gala & awards on October 6th at the Marriott Waterfront in Portland, OR with NORML founder Keith Stroup as a featured speaker.
By the numbers:
– 140+ attendees
– 21 speakers
– 5 members of Congress
– 150+ congressional meetings
– 1 goal: End marijuana prohibition.
In a quick deal between President Trump and Congress, a three-month budget continuing resolution will be in effect until December 8, 2017, maintaining current spending levels.
While this seems mundane (it is), it is important for marijuana policy because it guarantees a temporary extension of the Rohrabacher-Blumenauer protections for lawful medical marijuana programs from Attorney General Jeff Sessions.
Late Wednesday night, the House Rules Committee led by prohibitionist Representative Pete Sessions (R-TX) blocked multiple amendments related to marijuana from receiving consideration by the full House, thus ending their consideration and silencing the ability for the lower chamber to offer protections from Attorney General Jeff Sessions when it comes to cannabis.
The Medical Marijuana Research Act of 2017 amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.
Yesterday, NORML moderated a Facebook Congressional Conversation on marijuana law reform with Representatives Earl Blumenauer, Tom Garrett, Beto O’Rourke, and Justin Amash.
We discussed a wide range of issues including the needless burden of the federal driver’s license suspension mandate, access to medical marijuana, racial injustice, and pending bipartisan legislation to remove cannabis from the Controlled Substances Act.
This week, the House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.